Biotech
Page 2 of 19
FeaturesWill AI ever cure cancer? The multibillion-dollar race to bring the first AI-discovered drug to market
By Erika FryApril 3, 2025
TechAs a kid, she raised money to cure cystic fibrosis. Now she’s the CEO of a $2.6 billion genetic testing company
By Andrew NuscaMarch 31, 2025
By Alexa Mikhail and Beth GreenfieldMarch 24, 2025
Tech23andMe users told to consider deleting their data by California attorney general as the company files for bankruptcy
By Beatrice NolanMarch 24, 2025
LifeThis company is launching a genetic matching feature for future parents—and the CEO says ‘it has nothing to do with eugenics’
By Alexa MikhailMarch 23, 2025
By Michelle WernerMarch 10, 2025
LeadershipA few years ago 23andMe was worth $6 billion. Now CEO Anne Wojcicki is trying to buy it back for $42 million
By Lila MacLellanMarch 1, 2025
FinanceInvestors are plunking billions of dollars into AI-focused biopharma companies—a more than 300% increase from 2023
By Healthcare Brew and Maia AndersonJanuary 31, 2025
HealthSam Altman-backed AI biotech announces $1 billion for its lofty goal: adding 10 years to human life span
By Beth GreenfieldJanuary 24, 2025
HealthPharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers
By Lindsey LeakeJanuary 16, 2025
By Robert Langreth and BloombergDecember 18, 2024
HealthArnold Schwarzenegger is joining a Fortune 500 company to solve a great problem of his generation
By Lindsey LeakeNovember 13, 2024
Leadership23andMe’s entire board resigned on the same day. Founder Anne Wojcicki still thinks the startup is savable
By Lila MacLellanOctober 17, 2024
By Alexa MikhailOctober 6, 2024
Most Popular
